These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

775 related items for PubMed ID: 27031470

  • 1. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
    Ontiveros-Torres MÁ, Labra-Barrios ML, Díaz-Cintra S, Aguilar-Vázquez AR, Moreno-Campuzano S, Flores-Rodríguez P, Luna-Herrera C, Mena R, Perry G, Florán-Garduño B, Luna-Muñoz J, Luna-Arias JP.
    J Alzheimers Dis; 2016 Mar 22; 52(1):243-69. PubMed ID: 27031470
    [Abstract] [Full Text] [Related]

  • 2. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL, Tung YC, Liu F, Gong CX, Iqbal K.
    Alzheimers Res Ther; 2017 Jan 10; 9(1):1. PubMed ID: 28073379
    [Abstract] [Full Text] [Related]

  • 3. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE, Yao H, Beaulieu-Abdelahad D, Ait-Ghezala G, Mouzon B, Crawford F, Mullan M, Paris D.
    Acta Neuropathol Commun; 2017 Sep 06; 5(1):69. PubMed ID: 28877763
    [Abstract] [Full Text] [Related]

  • 4. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A.
    Neurodegener Dis; 2010 Sep 06; 7(6):379-88. PubMed ID: 20689242
    [Abstract] [Full Text] [Related]

  • 5. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y, Hua L, Yeh CK, Shen L, Ying M, Zhang Z, Liu G, Li S, Chen S, Chen X, Yang X.
    Theranostics; 2020 Sep 06; 10(25):11794-11819. PubMed ID: 33052247
    [Abstract] [Full Text] [Related]

  • 6. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
    Härtig W, Saul A, Kacza J, Grosche J, Goldhammer S, Michalski D, Wirths O.
    Neuropathol Appl Neurobiol; 2014 Feb 06; 40(2):106-20. PubMed ID: 23566195
    [Abstract] [Full Text] [Related]

  • 7. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.
    Rasool S, Martinez-Coria H, Wu JW, LaFerla F, Glabe CG.
    J Neurochem; 2013 Aug 06; 126(4):473-82. PubMed ID: 23672786
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    Ettcheto M, Petrov D, Pedrós I, Alva N, Carbonell T, Beas-Zarate C, Pallas M, Auladell C, Folch J, Camins A.
    J Alzheimers Dis; 2016 Jul 14; 54(1):233-51. PubMed ID: 27567882
    [Abstract] [Full Text] [Related]

  • 9. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.
    Howlett DR, Bowler K, Soden PE, Riddell D, Davis JB, Richardson JC, Burbidge SA, Gonzalez MI, Irving EA, Lawman A, Miglio G, Dawson EL, Howlett ER, Hussain I.
    Histol Histopathol; 2008 Jan 14; 23(1):67-76. PubMed ID: 17952859
    [Abstract] [Full Text] [Related]

  • 10. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT, Wang ZJ, Cai HY, Yuan L, Hu MM, Wu MN, Qi JS.
    Neurosci Bull; 2018 Oct 14; 34(5):736-746. PubMed ID: 30099679
    [Abstract] [Full Text] [Related]

  • 11. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
    Giuliani D, Ottani A, Zaffe D, Galantucci M, Strinati F, Lodi R, Guarini S.
    Neurobiol Learn Mem; 2013 Sep 14; 104():82-91. PubMed ID: 23726868
    [Abstract] [Full Text] [Related]

  • 12. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Sep 14; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 13. Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.
    Ferrer I.
    Neurotox Res; 2004 Sep 14; 6(6):469-75. PubMed ID: 15658002
    [Abstract] [Full Text] [Related]

  • 14. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ, Rudinskiy N, Herrmann AG, Croft S, Kim JM, Petrova V, Ramos-Rodriguez JJ, Pitstick R, Wegmann S, Garcia-Alloza M, Carlson GA, Hyman BT, Spires-Jones TL.
    Eur J Neurosci; 2016 Dec 14; 44(12):3056-3066. PubMed ID: 27748574
    [Abstract] [Full Text] [Related]

  • 15. Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology.
    Rosenberg RN, Fu M, Lambracht-Washington D.
    Alzheimers Res Ther; 2018 Nov 20; 10(1):115. PubMed ID: 30454039
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J, Lauretti E, Craige CP, Praticò D.
    J Alzheimers Dis; 2014 Nov 20; 41(3):729-37. PubMed ID: 24662099
    [Abstract] [Full Text] [Related]

  • 17. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM.
    J Neurochem; 2007 Aug 20; 102(4):1053-63. PubMed ID: 17472708
    [Abstract] [Full Text] [Related]

  • 18. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK, Park J, Han D, Yang J, Kim A, Woo J, Kim Y, Mook-Jung I.
    Mol Neurodegener; 2018 Jan 16; 13(1):2. PubMed ID: 29338754
    [Abstract] [Full Text] [Related]

  • 19. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C, Aranguiz F, Varela-Nallar L, Inestrosa NC.
    Brain Pathol; 2016 Jan 16; 26(1):62-74. PubMed ID: 25763997
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K, Prelli F, Mehta P, MacMurray C, Goñi F, Wisniewski T.
    Alzheimers Res Ther; 2018 Jun 18; 10(1):54. PubMed ID: 29914551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.